Skip to search formSkip to main contentSkip to account menu

CADI-05

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

TLR Agonist CADI-05

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Abstract 1582: Therapeutic vaccine for pancreatic cancer
Cadi-05 (Heat killed mycobacterium w) is a potent TLR 2 agonist and induces pure potent Th1 response. In advanced Non small cell… 
2011
2011
Open-label, randomized multicenter phase II clinical trial of a toll-like receptor-2 (TLR2) agonist mycobacterium w (Cadi-05) in combination with paclitaxel plus cisplatin versus paclitaxel plus…
7501 Background: TLR2 agonist, mycobacterium w (Cadi-05), a non-specific immunomodulator and pure Th 1 response enhancer has… 
2006
2006
Poly-TLR agonist polyantigenic vaccine cadi-05 in advanced nonsmall cell lung cancer
2905 Cadi-05 is a novel Poly-TLR, poly-antigenic vaccine containing Mycobacterium W. It is a potent Th1 response enhancer as… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)